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Abstract 
Ischemic stroke is one of the most prevalent sources of disability in the world. The major brain tissue 
damage takes place upon the reperfusion of ischemic tissue. Energy failure due to alterations in 
mitochondrial metabolism and elevated production of reactive oxygen species (ROS) is one of the main 
causes of brain ischemia-reperfusion (IR) damage. Ischemia resulted in the accumulation of succinate in 
tissues, which favors the process of reverse electron transfer (RET) when a fraction of electrons derived 
from succinate is directed to mitochondrial complex I for the reduction of matrix NAD
+
. 
We demonstrate that in intact brain mitochondria oxidizing succinate, complex I became damaged 
and was not able to contribute to the physiological respiration. This process is associated with a decline in 
ROS release and a dissociation of the enzyme’s flavin. This previously undescribed phenomenon 
represents the major molecular mechanism of injury in stroke and induction of oxidative stress after 
reperfusion. We also demonstrate that the origin of ROS during RET is flavin of mitochondrial complex 
I. Our study highlights a novel target for neuroprotection against IR brain injury and provides a sensitive 
biochemical marker for this process. 
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Introduction 
Ischemic stroke occurs as a result of a blockage of blood flow to the brain. It is one of the most 
prevalent sources of disability in modern times, almost pandemics in developed countries, with the 
number of people affected ~1,184 per 100,000 population 
1
. It is a consensus that brain tissue damage 
occurs upon reperfusion of ischemic tissue. Mitochondrial bioenergetics failure and elevated production 
of reactive oxygen species (ROS) are considered among the major causes of brain ischemia-reperfusion 
(IR) tissue damage. The mitochondrial IR-induced damage is usually delayed; after seemingly complete 
recovery of aerobic ATP production in the first phase of reperfusion, mitochondria function fails later on, 
a process is termed “secondary energy failure”. The molecular mechanisms of this secondary failure are 
not understood (reviewed in 
2
). Several putative mechanisms had been suggested for IR-induced brain 
mitochondria damage 
3-5
, including a decline in mitochondrial Complex I function caused by IR 
6, 7
. 
However, the reasons for Complex I failure are also not known.  
Mitochondrial Complex I oxidizes tricarboxylic acid cycle (TCA)-produced NADH by ubiquinone in 
the inner mitochondrial membrane. Electrons from NADH are accepted by non-covalently bound flavin 
(FMN) and further transferred to ubiquinone in the inner mitochondrial membrane 
8, 9
, generating the 
protonmotive force 
10
 which fuels the production of ATP by mitochondrial ATPase. The electron transfer 
in Complex I can be reversed so the enzyme can catalyze the reduction of matrix NAD
+
 by the ubiquinol 
at the expense of mitochondrial membrane potential 
11, 12
. This reaction is termed “reverse electron 
transfer” (RET). Despite the fact of that more than 55 years since the first observation of RET in the intact 
mitochondria have passed 
11, 13
 not much is known about regulation and significance of this process in 
situ. However, it is known that the minimal requirements for this reaction to occur are the presence of the 
membrane potential and a high level of ubiquinone reduction, which in the brain can be provided by 
succinate oxidation. The accumulation of succinate well above its physiological levels is a common 
marker of brain ischemia. In rat brain, 5 min of ischemia results in ~300% increase in succinate 
concentration, to the millimolar range 
14, 15
. Upon reperfusion, succinate in post-ischemic brain returns to 
the control levels only after 30-40 min 
16
. Succinate had also been shown to inhibit the oxidation of 
pyruvate and other NAD-linked respiratory substrates and cause an over-reduction of mitochondrial 
pyridine nucleotides 
17
. Succinate had been proposed lately to be the primary oxidized substrate in brain 
homogenates of post-ischemic neonatal mouse brains (Dr. Vadim Ten’s lab, submitted). 
Recently, succinate-driven RET emerged as a potential area of great physiological importance 
18-21
. 
In this manuscript, we demonstrate that in intact brain mitochondria under conditions of RET, prolonged 
succinate oxidation damages Complex I by inducing a dissociation of the enzyme’s flavin. This 
previously undescribed phenomenon may represent the major molecular mechanism of IR-induced 
secondary energy failure in stroke. Our data also demonstrate that the origin of ROS during RET is flavin 
of mitochondrial Complex I. 
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Materials and Methods. 
Intact mitochondria isolation for in vitro studies 
The animal protocol was approved by the Institutional Animal Care and Use Committee of Weill 
Cornell Medicine. All experiments were conducted in accordance with the Guidelines for the Care and 
Use of Laboratory Animals of the National Institutes of Health and the ARRIVE guidelines. To isolate 
intact mitochondria a modified protocol combining differential centrifugation and digitonin treatment was 
used 
22
. The forebrain hemispheres of C57BL/6 8-10 weeks male mice were excised and immediately 
immersed into ice-cold isolation medium (225 mM mannitol, 75 mM sucrose, 20 mM HEPES-Tris, 1mM 
EGTA, pH 7.4) supplemented with 1 mg/ml BSA. Tissue was homogenized with 40 strokes by pestle “B” 
(tight) of a Dounce homogenizer in 10 ml of the isolation medium, diluted two-fold and transferred into 
centrifuge tubes. The homogenate was centrifuged at 5,900 g for 4 min in a refrigerated (+4°C) Beckman 
centrifuge. The supernatant was centrifuged at 12,000g for 10 min, and the pellets were resuspended in 
the same buffer and 0.02% digitonin was added. The suspension was homogenized briefly with five 
strokes in a loosely fitted Potter homogenizer and centrifuged again at 12,000g for 10 min, then gently 
resuspended in the isolation buffer without BSA and washed once by centrifuging at 12,000g for 10 min. 
The final mitochondrial pellet was resuspended in 0.1 ml of washing buffer and stored on ice. 
 
Accessing respiration and ROS production in intact mitochondria. 
Mitochondrial respiration and extramitochondrial release of H2O2 were measured using a high-
resolution respirometer (Oroboros) equipped with two-channel fluorescence optical setup to monitor 
simultaneously oxygen level and fluorescence in 2 ml of mitochondrial suspension. For H2O2 
measurements fluorescence was recorded using a green 525 nm LED as an excitation light source, a 
photodiode (S2386-8K, Hamamatsu Photonics, Japan) as a sensor, and an emission filter with cut off 580 
nm (#34, Rosco Laboratories, USA), fixed in a 3D printed mount (Form2, Formlabs, USA). The 
photodiode was connected to the amperometric port of the Oxygraph and the fluorescence was recorded 
using the Datlab software. The calibration of Amplex UltraRed response was performed at the end of the 
run by adding several 93 pmol/ml aliquots of freshly made H2O2 to the chamber containing all the 
components of the assay. 
Mitochondria (0.14-0.18 mg of protein) were added to 2 ml respiration buffer composed of 125 mM 
KCl, 0.2 mM EGTA, 20 mM HEPES-Tris, 4 mM KH2PO4, pH 7.4, 2 mM MgCl2, 2 mg/ml BSA, 10M 
Amplex UltraRed (Invitrogen) and 4 U/ml horseradish peroxidase at 37°C. The following substrates were 
used: 2 mM malate and 5 mM pyruvate or 5 mM succinate and 1 mM glutamate. To initiate State III 
respiration 200 M ADP was added to the mitochondrial suspension. Respiration was fully sensitive 
(inhibited) by 1 mM cyanide or 1 M antimycin A. 
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To enable us to rapidly change oxygen concentration in the mitochondrial suspension we have 
included a gas headspace (1 ml) above the measurement chamber. The headspace could be continuously 
purged with humidified gaseous nitrogen through the stopper at a rate of 10-60 ml/min. By varying the 
partial pressure of gaseous nitrogen in the headspace we are able to control its concentration in the liquid 
sample via N2 exchange between the two phases. When required, the gas flow was turned off, and the 
stoppers moved to seal the oxygen chamber so that no headspace remained. 
 
Complex I activity measurements in disrupted mitochondria  
The NADH:HAR oxidoreductase activity of Complex I 
23
 was determined spectrophotometrically 
using a plate reader (SpectraMax M5, Molecular Devices, USA). Oxidation of 150 M NADH (340nm = 
6.22 mM
-1cm-1) by 1mM HAR was followed at 340 nm in 0.2 ml of standard respiration buffer (pH=7.5) 
supplemented with 25 g/ml alamethicin (to disrupt mitochondria), 2 mM MgCl2 , 1mM cyanide and 
0.01-0.025 mg protein/ml mitochondria. 
 
Flavin fluorescence measurements 
The flavin fluorescence in mitochondria oxidizing succinate was measured by Hitachi 7000 
spectrofluorimeter set at 450 nm excitation and 525 nm emission. The reaction was carried out under 
exactly the same conditions as the respiratory assays, except that Amplex UltraRed and horseradish 
peroxidase were omitted from the medium. Special controls for photobleaching of the preparation during 
prolonged measurements were performed. 
 
Mitochonfrial membrane potential measurements 
Mitochondrial membrane potential was asessed indirectly using membrane-permeable fluorescent 
safranin O probe (2 µM), excitation 525 nm, emission 580 nm essentially as described previously 
24
. 
 
All chemicals were purchased from Sigma unless stated otherwise. Protein content was determined 
by BCA assay with deoxycholate (0.1%) for solubilizing the mitochondrial membranes (ThermoFisher, 
USA). All activities were measured at 37°C except NADH:HAR (25°C). All results are expressed as 
means ± SEM. Six different preparations of mitochondria were tested. When comparing different groups, 
a two-sample t-test was used. Other experimental details are described in the legends to the figures. 
 
6 
 
Results. 
In order to assess the oxygen dependence of the hydrogen peroxide emission from intact brain mitochondria 
first we carried out experiments in the closed respirometer chamber. Fig. 1A shows representative traces of oxygen 
consumption and hydrogen peroxide release by intact brain mitochondria oxidizing NAD-dependent substrates, or 
succinate. Table 1 shows quantitative characteristics of the respiration and H2O2 emission. The rate of H2O2 
emission upon coupled succinate oxidation was around tenfold higher than in the presence of NAD-dependent 
substrates. As expected, the succinate-supported H2O2 production was suppressed by either adding ADP or an 
uncoupler, as well as by rotenone, confirming that ROS generation was fueled by RET. It should be noted that the 
addition of succinate rapidly induces reduction of the entire pool of matrix NAD(P) 
11
. Therefore, in the steady-state 
conditions of the succinate oxidase reaction in vitro, there is no RET as a classical reduction of matrix nucleotides 
showed by Britton Chance 
11
. In the present paper, we use term RET-like conditions describing the process of 
oxidation of succinate by a fully competent respiratory chain of intact mitochondria in steady-state. 
We estimated the effect of the oxygen concentration on H2O2 release during the oxidation of succinate by 
purging the headspace in our system with nitrogen to quickly reduce the partial pressure of O2 in the solution. RET-
associated H2O2 release during succinate oxidation was almost linearly dependent on the oxygen concentration in 
the medium (Fig. 1B).  
As shown in Fig. 2A, during the time course of succinate oxidase reaction in the closed chamber when the 
oxygen gradually decreases due to the respiratory activity, the rate of H2O2 release also declines. We would like to 
emphasize that the resting respiration rate during the oxidation of succinate stayed almost constant at the wide range 
of oxygen concentration and dropped sharply only at 20-25 µM [O2]. In order to evaluate the rate of H2O2 emission 
from mitochondria at constant concentration of oxygen (around 190 µM [O2]) we carried our similar experiments in 
the open respirometer chamber. Unexpectedly, we also observed a decline of H2O2 release rates during RET in the 
open chamber (Fig. 2D), while the oxygen concentration in the medium did not change (Fig. 2B). 
To further investigate this phenomenon, we tested the effect of amount of mitochondria in the medium to the 
observed decline of the H2O2 emission rate. Representative traces of the H2O2 release rate decline in time at 
different concentrations of mitochondrial protein in the assay are shown in Fig. 3A. The half-time of this decline 
was around 4.5 min (Fig. 3B) and was not dependent on the concentration of mitochondria in the range of 0.1-0.5 
mg of protein/ml. Therefore, the decline was not due to the accumulation of any reaction product in the medium. 
The inhibitory action of accumulated H2O2 under our conditions is not likely, because, upon oxidizing NAD-linked 
substrates, there is virtually no accumulation of H2O2 in the suspension of mitochondria, whereas, during RET-
catalyzed H2O2 generation, the accumulation is minimal peaking at about 30 nM of H2O2 
25
. In agreement with that, 
preincubating intact mitochondria with 45-90 µM H2O2 for 5-10 min before the addition of substrates did not 
change the parameters of the H2O2 rates decline. The addition of 50 U/ml MnSOD to the medium did not change the 
dynamics of H2O2 emission decline (data not presented). Therefore, it is unlikely that in our conditions, ROS 
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produced during RET had pronounced damaging effect on mitochondrial enzymes involved in RET. We found that 
the only condition that decreased the rate of decline was temperature. At 25°C in the open chamber, the half-time of 
the H2O2 release rate decline was increased to 10-12 min (not shown). 
Several factors  directly affects the rate of H2O2 release during coupled oxidation of succinate: absolute 
activitiy of respiratory chain enzymes and the magnitude of membrane potential across the inner mitochondrial 
membrane. Therefore, first we tested the dependence of H2O2 release rate during RET on the potential dependent 
fluorescence of safranin O 
26
. As shown in Fig. 3C, no significant changes in the dye fluorescence was observed 
during RET, indicating that membrane potential was mainly preserved during this time interval changing only by 
less than 8%.  
Potentially, the rate of H2O2 release during RET also depends on the activity of complexes I and II. Therefore, 
we have assessed the respiratory activities of mitochondria before and after incubation under RET conditions. As 
shown in Fig. 4A, succinate oxidase activity in both resting and ADP-stimulated state was unaffected by 20 min 
incubation. Contrary to that, ADP-stimulated respiration on malate and pyruvate was decreased by around 75% 
(Fig. 4B). This strongly indicates that prolonged RET affected the NADH:ubiquinone reductase activity of 
complex I. Consequently, it is highly likely that an impairment of complex I function was responsible for the 
decline in H2O2 emission rate during the prolonged oxidation of succinate (Fig. 3A). 
The loss of NADH:ubiquinone reductase activity of mitochondrial complex I can be caused by several factors. 
To elucidate the potential mechanism, we have assessed the changes in the activity of complex I during the time 
course of the decline with an artificial electron acceptor HAR (NADH:HAR reductase) spectrophotometrically in 
permeabilized mitochondria (Fig. 5). We found that NADH:HAR activity decreased in parallel with the rate of H2O2 
release by intact mitochondria. Moreover, the addition of 10µM exogenous FMN had resulted in a partial recovery 
of NADH:HAR activity. These data unequivocally indicate that the decline in the rate of H2O2 generation was due 
to the loss of complex I flavin caused by prolonged succinate oxidation under RET conditions. 
To further support this conclusion, we have assessed flavin fluorescence in intact mitochondria exactly under 
the same conditions as those employed to measure H2O2 emission (Fig. 6A). A fast decline of the fluorescence 
intensity after additions of substrates indicating a reduction of flavin was observed for the first 2 min. The decline 
was followed by a slow increase in fluorescence. This could be caused by either an increase in flavin’s fluorescence 
intensity upon its dissociation from the protein or by a fast autoxidation of the reduced flavin in the matrix. The 
dynamics of the flavin fluorescence intensity (Fig. 6A) followed exactly the inverted pattern of the decline in H2O2 
emission rate (Fig. 6B). This indicates that in steady-state conditions, the rate of H2O2 emission upon RET was 
directly proportional to the amount of Complex I-bound flavin. 
  
8 
 
Discussion 
In this study, we have shown that prolonged oxidation of succinate by brain mitochondria under RET conditions 
stimulates dissociation of flavin from mitochondrial Complex I and results in the loss of activity of the enzyme. In 
turn, this impairs the oxidation of NAD-linked (physiological) substrates as well as the generation of ROS by 
mitochondria. 
The process of RET, first observed more than half a century ago 
11, 13
 has recently gained significant attention in 
ischemia/reperfusion studies. First, after a period of oxygen deprivation succinate level is elevated in highly 
metabolizing tissues such as the brain 
14, 15, 27
 and heart 
18, 28
. Potentially, given the availability of substrate and 
energization of the inner mitochondrial membrane, RET can take place after oxygen is resupplied to the tissue. 
Second, succinate-dependent respiration is characterized by the highest rates of ROS production by mitochondria 
18, 
19, 29-32
. In our study, RET also provided the greatest rate in H2O2 release equivalent to around 3.5% of total oxygen 
consumption, which is very close to what observed for the mitochondria from adult rat brain 
26
. Therefore, in 
postischemic tissue, RET is active and may render injury to the tissue found in several models of tissue ischemia 
18, 
33
. 
Mitochondrial complex I is the most sensitive respiratory enzyme to ischemia in the brain 
6, 7, 19, 34
. The 
mechanism of complex I damage during this process is not fully understood. Surprisingly, incomplete ischemia 
results in greater complex I damage in a rat model of brain oxygen deprivation 
35
. Most likely, succinate 
accumulated in the ischemic core may diffuse to the surrounding tissues and have devastating consequences to the 
penumbra area, where both substrates (oxygen and succinate) are available. This may explain greater decrease on 
mitochondrial complex I damage in the models of incomplete brain ischemia. 
In our initial experiments, we observed a linear dependence of H2O2 release by intact brain mitochondria 
during RET which is in accordance with the earlier studies on the intact brain in vivo 
36
. Superoxide anion 
generation by submitochondrial particles oxidizing succinate 
37
 also showed a linear dependence of H2O2 production 
upon oxygen concentration. This is in apparent disagreement with recent studies of liver mitochondria 
38
 and may be 
due to the different enzymatic composition of the preparations from different tissues. 
The unexpected observation in our further study is the gradual decline of H2O2 release rate by intact brain 
mitochondria during oxidation of succinate at constant oxygen level. The rate of decline is not dependent on the 
concentration of mitochondria (0.1-0.5 mg of protein/ml) and half-time of the process is around 4.5 min. We 
assessed activities of complexes I and II before and after oxidation of succinate and found that only complex I 
activity is strongly diminished after mitochondria were exposed to RET-like conditions. We found that this decline 
is due to the dissociation of the flavin from mitochondrial complex I since NADH:HAR reductase activity of the 
enzyme declines in simultaneously with ROS production. Artificial acceptor HAR takes electrons directly from the 
flavin of complex I at the hydrophilic domain and this process does not involve downstream components of the 
enzyme such as iron-sulfur clusters and ubiquinone-binding site 
23, 39
. Moreover, supplementation of exogenous 
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FMN to the assay medium partially recovered NADH:HAR reductase activity of enzyme supporting the critical role 
of flavin in the process of RET-induced inactivation. 
Under RET conditions, electrons from succinate are transferred to ubiquinone and then directed to the oxygen 
via downstream complex III and cytochrome c oxidase and partially upstream to complex I. The above process 
provides respiratory activity and builds up a potential across the mitochondrial membrane, and the latter one is 
likely to be responsible for the generation of ROS upstream of ubiquinone binding site of complex I. In the steady 
state, coupled succinate oxidation would maintain high NAD(P)H/NAD(P)
+
 ratio in the matrix and increases 
reduction of the tightly-bound FMN of complex I. Non-covalently bound FMN resides on the bottom of a deep 
cavity of the catalytic subunit NDUFV1 
8
 and is accessible to oxygen, therefore, reduced flavin favors ROS 
formation. FMN has been proposed to be the main site of ROS-production in complex I in several studies 
40-44
. 
However, the FeS clusters of Complex I 
45, 46
 and semiquinone 
47, 48
 had also been discussed as the source of ROS 
origin (see 
49
 for review). Our experiments strongly support the idea that it is exactly FMN and not the FeS clusters, 
is the major site of H2O2 generation in intact brain mitochondria in conditions of RET during succinate oxidation. 
Another important finding of our studies is that FMN quickly dissociates from the enzyme in intact brain 
mitochondria when it is reduced in the RET-like conditions. Reductive dissociation of FMN from the three-subunit 
FP-fragment of complex I 
50
, as well as from the intact bovine and isolated prokaryotic enzyme 
51, 52
 have been 
demonstrated in vitro. The conditions required for dissociation of FMN in these studies (high pH or the presence of 
the detergents) are hardly related to any conceivable physiological situation. The significant change in angle of a 
butterfly-like structure of the isoalloxazine ring 
53
 and a general loosening of the complex I molecule structure upon 
reduction 
54
 may contribute to the strong change in FMN affinity to its binding site. It should be stressed, that 
release of complex I reduced flavin in the mitochondrial matrix may result not only in complex I impairment, but 
also may lay at the basis of oxidative stress after IR. Fully reduced flavin reacts avidly (within seconds) with 
oxygen, and H2O2 is the predominant product 
55
. After the release, the reduced flavin can be readily oxidized by 
molecular oxygen resulting in an increase of local ROS generation in the matrix. Oxidized FMN molecule can 
either be metabolized or reinserted back to complex I. At present, the process of non-covalent inclusion of FMN to 
complex I and the general mechanisms by which mitochondria can provide their flavin cofactors remains 
unsolved
56
. 
Our observation suggests that the main cause of decrease of complex I activity after ischemia is the reversible 
release of flavin from the enzyme. This is first direct evidence of the mechanism of complex I damage during 
oxidation of succinate in postischemia-like conditions. Our in vitro findings were corroborated by in vivo data from 
transient cerebral ischemia by middle cerebral artery occlusion where 35 min ischemia significantly decreased the 
content of mitochondrial membrane non-covalently bound FMN (Kahl et al., 2017, J.Neurosci., under revision). To 
our knowledge, the only report describing the loss of mitochondrial flavin during cardiac ischemia in dogs was 
published more than 35 years ago 
57
. Also of note, a high proportion of acute stroke patients manifested riboflavin 
10 
 
deficiency following reperfusion, however, the clinical significance of these findings is not yet known 
58
. Further 
studies are expected to shed light on the mechanism of complex I inactivation in brain ischemia and is currently 
underway in our laboratory. 
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Figure Legends 
Fig. 1. H2O2-release during the forward and reverse electron transfer. Representative traces of respiration (top) and 
generation of H2O2 (bottom) by intact mitochondria from mouse brain. A, The reaction was started by 
addition of mitochondria 0.16 mg of protein/ml to the medium composed of 125 mM KCl, 0.2 mM EGTA, 
20 mM HEPES-Tris (pH 7.4), 4 mM KH2PO4, 2 mM MgCl2, 2 mg/ml BSA, 10 M Amplex UltraRed and 4 
U/ml horseradish peroxidase at 37°C. Substrates were either 5mM pyruvate and 2mM malate (right) or 5 
mM succinate and 1 mM glutamate (left). Black traces correspond to oxygen concentration (top) and 
Amplex UltraRed fluorescence (bottom). The rate of the change of these signals per minute is shown in red. 
B, Release of H2O2 during coupled oxidation of 5 mM succinate and 1 mM glutamate as a function of 
oxygen concentration. 100% rate corresponds to 1,400 pmol H2O2×min
-1
×mg protein
-1
. Oxygen 
concentration as measuring directly by the Oroboros respirometer was rapidly varied by continuously 
purging the headspace with nitrogen as described in Materials and Methods section. 
Fig. 2. Consumption of oxygen and H2O2 release in closed (A, C) and open (B, D) respirometer chamber. Oxygen 
concentration (top) and Amplex UltraRed fluorescence (bottom) were measured simultaneously in 125 mM 
KCl, 0.2 mM EGTA, 20 mM HEPES-Tris, 4 mM KH2PO4, pH 7.4, 2 mM MgCl2, 2 mg/ml BSA, 0.25mg/ml 
of mouse brain mitochondria, 5 mM succinate, 1 mM glutamate 10µM Amplex UltraRed and 4 U/ml 
horseradish peroxidase. Black traces correspond to oxygen concentration (top) and raw Amplex UltraRed 
fluorescence (bottom). The rates of the change of these signals per minute are shown in red. 
Fig. 3. H2O2 release rate decline at different protein concentration and safranin response. A, three different protein 
concentrations were used to monitor H2O2 release in RET-like conditions. Curves 1-3 correspond to 0.5, 
0.25, 0.125 mg of protein/ml protein in the measuring assay. Dashed lines show fitting of exponential decay 
function. B, Half-life of exponential decay of H2O2 release rate at difference protein concentrations (n=3-4 
for each data point). C, Safranin O fluorescence after addition of 5 mM succinate and 1 mM glutamate to 
0.15 mg of protein/ml. Assay conditions are as in Fig. 2B, except 2 µM safranin substituted Amplex 
UltraRed and horseradish peroxidase in C. Concentration of FCCP was 0.1 µM. 
Fig. 4. Effect of incubation of intact brain mitochondria in RET-like conditions on the succinate- and NADH-
dependent respiration (A and B, respectively). Mitochondria 0.15-0.2 mg of protein/ml were incubated in the 
presence of 5 mM succinate and 1 mM glutamate (as in Fig. 2B). After 2min (gray) and 20 min (white) 1 µM 
rotenone was added for the registration of succinate oxidase only (A). Alternatively, 25 nM atpenin, 5 mM 
pyruvate and 2 mM malate were added for the NAD
+
-dependent respiration (B). After the additions, 
respirometer chamber was closed and resting respiration (state II) was measured. ADP-stimulated (state III) 
respiration was measured after addition of 0.5 mM ADP.  
Fig. 5. Effect of incubation of intact brain mitochondria in RET-like conditions on NADH:HAR reductase activity. 
Mitochondria 0.3 mg of protein/ml were incubated in the presence of 5 mM succinate and 1 mM glutamate 
as in Fig. 2B and H2O2 release rate was monitored after reaching the maximum (squares). Small aliquots 
were taken in time and NADH:HAR reductase activity was assayed as described in Materials and Methods 
section with or without 10 µM FMN (black and red circles respectively). 100% rate of H2O2 release 
corresponds to 1,530±150 pmol H2O2×min
-1
×mg protein
-1
. 
Fig. 6. Flavin fluorescence recovery (A) and dynamics of H2O2 release (B) in intact brain mitochondria during 
oxidation of succinate in RET-like conditions. Parameters of the assay are in Fig. 2, except 0.4 mg of 
protein/ml mitochondria was used. AmplexUltra Red and horseradish peroxidase were absent from the 
medium for flavin fluorescence measurements. Black traces correspond to Amplex UltraRed fluorescence  
and the rate of H2O2 release per min per mg of protein is shown in red. Note that fluorescence response 
(averaged from three measurements) is shown in inverted scale. 
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Tables 
 
Table 1. Respiration activities and H2O2 release by coupled mouse brain mitochondria. 
 
Respiration, 
nmol O2×min
-1
×mg
-1
 
Release of H2O2
*
, 
pmol H2O2×min
-1
×mg
-1
 
Malate +Pyruvate 15.26.3 13718 
+ADP (0.5 mM) 107.524.8 3412 
Succinate+Glutamate 403.1 1,560300 
+ADP (0.5 mM) 20121.8 559 
+FCCP (0.2 M) 165.127.7 9718 
+Rotenone (1M) 35.03.2 13219 
 
* measured simultaneously in 125 mM KCl, 0.2 mM EGTA, 20 mM HEPES-Tris, 4 mM 
KH2PO4, pH 7.4, 2 mM MgCl2, 2 mg/ml BSA, 10 M Amplex UltraRed and 4 U/ml 
horseradish peroxidase at 37°C, 0.14-0.19 mg of protein/ml mitochondrial protein. 
Substrates were either 5mM malate and 2mM pyruvate or 5 mM succinate and 1 mM 
glutamate. Values are given as meanSEM. Three different preparations of mitochondria 
were used, all conditions were repeated in triplicates. 
200 s
Fluorescence
0.15 AU
[O ]2
 50 mM
Rate
 24 mM O /min2
Rate
0.18 AU/min
Rate
0.06 AU/min
Fluorescence
1 AU
Mito
Mito
ADP
ADP
Mito
ADP
Mito
ADP
0 20 40 60 80 100 120 140 160 180
20
40
60
80
100
[O ], µM2
B
A
Ra
te
 o
f H
O
 re
le
as
e,
 %
2
2
Fig. 1. H O -release during the forward and reverse electron transfer. Representative traces of respiration (top) and 2 2
generation of H O  (bottom) by intact mitochondria from mouse brain. A, The reaction was started by addition of 2 2
0.16 mg protein/ml mitochondria to the medium composed of 125 mM KCl, 0.2 mM EGTA, 20 mM HEPES-Tris (pH 
7.4), 4 mM KH PO , 2 mM MgCl , 2 mg/ml BSA, 10 mM Amplex UltraRed and 4 U/ml horseradish peroxidase at 2 4 2
37°C. Substrates were either 5 mM pyruvate and 2 mM malate (right) or 5 mM succinate and 1 mM glutamate (left). 
Black traces correspond to oxygen concentration (top) and Amplex UltraRed fluorescence (bottom). The rate of the 
change of these signals per minute is shown in red. B, Release of H O  during coupled oxidation of 5 mM succinate 2 2
-1and 1 mM glutamate as a function of oxygen concentration. 100% rate corresponds to 1,400 pmol H O ×min ×mg 2 2
-1protein . Oxygen concentration as measuring directly by the Oroboros respirometer was rapidly varied by 
continuously purging the headspace with nitrogen as described in Materials and Methods section.
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Fig. 3. H O  release rate decline at different protein concentration and safranin response. A, three different protein concentrations were used to 2 2
monitor H O  release in RET-like conditions. Curves 1-3 correspond to 0.5, 0.25, 0.125 mg protein/ml protein in the measuring assay. 2 2
Dashed lines show fitting of exponential decay function. B, Half-life of exponential decay of H O  release rate at difference protein 2 2
concentrations (n=3-4 for each data point). C, Safranin O fluorescence after addition of 5 mM succinate and 1 mM glutamate to 0.15 mg 
protein/ml. Assay conditions are as in Fig. 2B, except 2 µM safranin substituted Amplex UltraRed and horseradish peroxidase in C. 
Concentration of FCCP was 0.1 µM.
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reductase activity. Mitochondria 0.3 mg protein/ml were incubated in the presence of 5 
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NADH:HAR reductase activity was assayed as described in Materials and Methods 
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Fig. 6. Flavin fluorescence recovery and dynamics of H O  release in intact brain mitochondria 2 2
during oxidation of succinate in RET-like conditions. Parameters of the assay are in Fig. 2, 
except 0.4 mg protein/ml mitochondria was used. AmplexUltra Red and horseradish 
peroxidase were absent from the medium for flavin fluorescence measurements. Black 
traces correspond to Amplex UltraRed fluorescence  and the rate of H O  release per min 2 2
per mg of protein is shown in red. Note that fluorescence response (averaged from three 
measurements) is shown in inverted scale.
